NTRK1 and neoplasm: Excitingly, several tumor antigens show encouraging results in preclinical studies, including members of receptor tyrosine kinase (RTK)34, 35, cell surface proteins36, ganglioside37, stress ligand38, tumor serum marker39 and others.